Tevogen Bio (TVGN) PT Lowered to $2 at D. Boral Capital

D. Boral Capital analyst Jason Kolbert lowered the price target on Tevogen Bio (NASDAQ: TVGN) to $2.00 (from $5.00) while maintaining a Buy rating.

The analyst comments "We are lowering our price target as a result of multiple factors. The fall in the stock price increases the company's dilution risk. In addition, we are pushing back the timing of commercialization too. These changes combine to lower our target valuation from $5.0 to $2.0."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• Freedom Broker Upgrades Serve Robotics (SERV) to Buy